Mechanism of action of COMBIGAN The combination of brimonidine and timolol in an ophthalmic solution reduces intraocular pressure (IOP) by reducing aqueous humour production and increasing uveoscleral outflow.
This product contains a combination of brimonidine tartrate and timolol maleate. Each of these components is used to decrease elevated intraocular pressure.
Only registered users have access to the most valuable content of the FitEyes community: Blogs, Comments, FitEyes Discussion Group Archives, unique information on self-tonometry and other user-generated research.
You must register because we have content that cannot be viewed unless you agree to our terms and conditions.